USAMRIID | Global Biodefense

Menu

Latest stories

Medical Countermeasure Development

USAMRIID Seeks Isolation and Purification of Ovatoxins

Yersinia pestis concept illustration

Ology Bioservices Awarded DoD Contract for Countermeasures Against Bioweapons

More on pathogens and preparedness

NICBR Winter Symposium on Novel Therapeutics

by Global Biodefense January 24, 2019, 12:00 am
SIGA, USAMRIID Enter Agreement to Evaluate Post-Exposure Prophylactic for Smallpox

by Global Biodefense October 4, 2018, 3:30 am
Collaboration Among BARDA, DTRA, USAMRIID and Spero to Advance SPR994
Biodefense World Summit 2018

by Global Biodefense June 27, 2018, 12:00 am
USAMRIID Temporarily Halts Activity at BSL-3 and BSL-4 Laboratories

by Stephanie Lizotte June 2, 2018, 9:07 am
USAMRIID Awards Select Agent Research Reagents Contract

by Stephanie Lizotte May 16, 2018, 1:44 am
MIT, USAMRIID Develop Algorithm for Early Warning of Exposure to Pathogens
Monkeypox in Nigeria: The Value of Local Surveillance and Genetic Sequencing

by Global Biodefense February 19, 2018, 1:15 am
USAMRIID-Bavarian Nordic Smallpox Vaccine Phase 3 Study

by Global Biodefense February 19, 2018, 1:10 am
Enhancing the Efficacy of Adenovirus-5 Vectored Ebola Virus Vaccines

by Global Biodefense May 25, 2017, 9:36 am
Modernization of USAMRIID’s Biodefense Lab Management System
DoD to Study Omadacycline as Countermeasure for Plague, Anthrax

by Global Biodefense October 12, 2016, 9:46 am

Congratulations. You've reached the end of the internet.

Back to Top

Close